TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT05841563: Clinical Trial of PM54 in Advanced Solid Tumors Patients.

Sponsor: PharmaMar · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 125 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$10,053,120

Rescue Site Savings

+$6,628,776

Unlock Full NCT05841563 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05841563 Rescue Dossier →